Home › Trial NCT04986930
mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma
- Trial IDNCT04986930
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorAsan Medical Center
- Enrollment92
- Start date2021-08-14
- ConditionsPancreatic Adenocarcinoma · Pancreatic Cancer Non-resectable
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.